Clifton Craig Mo MD

Hematologic Oncology

Physician

450 Brookline AveBoston, MA 02215
Phone+1 617-582-7969

Dr. Mo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mo's full profile Already have an account?

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2010
National Capital ConsortiumResidency, Internal Medicine, 2004 - 2007
Yale School of MedicineClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2019 - 2028
ME State Medical License 2023 - 2028
OH State Medical License 2022 - 2028
VT State Medical License 2023 - 2026
MI State Medical License 2016 - 2021
MD State Medical License 2014 - 2019
VA State Medical License 2006 - 2018
WA State Medical License 2011 - 2015
American Board of Internal Medicine Medical Oncology
Join now to see all

Clinical Trials

Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma Start of enrollment: 2020 Nov 30
COMPLETED
PHASE1, PHASE2
agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2021 Mar 29
COMPLETED
PHASE1

Publications & Presentations

PubMed

A phase I/II study of twice-weekly ixazomib plus pomalidomide and dexamethasone in relapsed and refractory multiple myeloma.
Omar Nadeem, Robert A Redd, Peter M Barth, Trevor J Bayliss, Jacob P Laubach
Haematologica. 2026-05-28
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma.
Yuxin Liu, Clifton Mo, Shonali Midha, Monique Hartley-Brown, Hans C Lee
Expert Opinion on Investigational Drugs. 2026-05-01
2 citations
A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM).
Yuxin Liu, Ji Hyun Lee, Clifton C Mo, Taya Jamal Salman, Shahrier Hossain
Expert Opinion on Biological Therapy. 2026-03-01

Press Mentions

Doctors Testing Plasma as Immune TherapyMay 15th, 2020

Professional Memberships

American Society of Hematology - ASH
Member

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Janet Abrahm, MD
OncBoston, MA
Jeffrey Meyerhardt, MD
OncBoston, MA
Robert Haddad, MD
OncBoston, MA
Andrew Wagner, MD
OncBoston, MA
Peter Hammerman, MD
OncBoston, MA
Atish Choudhury, MD
OncBoston, MA
Eudocia (Quant) Lee, MD
OncBoston, MA
Christina Herold, MD
OncBoston, MA
Lauren Harshman, MD
OncBoston, MA
Elizabeth O'Donnell, MD
OncBoston, MA

Doximity / States / Massachusetts / Boston / Clifton Mo, MD

Dr. Clifton Mo, Dr. Clifton Mo, MD, Dr. C Mo, Dr. Clifton Craig Mo